Posters
Autoantibodies against citrullinated and carbamylated proteins in RA patients may be associated with more active disease and higher risk of developing joint erosions, and Vectra® is a blood test that yields a RA disease activity (DA) score from 1 to 100 that is low, moderate or high. In this abstract, 120 patient samples were analyzed to assess the relationship of DA as measured by Vectra® Score and the presence of novel autoantibody markers with potential prognostic value.